Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Newron Plans Funding Round As CNS Drug Nears Phase III

Dec. 3, 2003

By Cormac Sheridan

Abbott Pulls Out Of Diabetes Collaboration With Karo Bio

Nov. 19, 2003

By Cormac Sheridan

Abbott Pulls Out Of Diabetes Collaboration With Karo Bio

Nov. 19, 2003

By Cormac Sheridan

T-cellic Raises DKK40M For Its T-Cell Guided Therapy'

Nov. 12, 2003

By Cormac Sheridan

T-cellic Raises DKK40M For Its T-Cell Guided Therapy'

Nov. 12, 2003

By Cormac Sheridan

Swedish Research Coalition Seeking More R&D Support

Nov. 5, 2003

By Cormac Sheridan

Swedish Research Coalition Seeking More R&D Support

Nov. 5, 2003

By Cormac Sheridan

XCellentis Reports Positive Phase II LyphoDerm Results

Oct. 29, 2003

By Cormac Sheridan

Focused On Drug Development, BioInvent In-Licenses Program

Oct. 29, 2003

By Cormac Sheridan

XCellentis Reports Positive Phase II LyphoDerm Results

Oct. 29, 2003

By Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 25, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 25, 2024.
J&J’s Ottava robotic system approved for US pivotal trial
BioWorld MedTech
Johnson & Johnson received U.S. FDA investigational device exemption to begin the pivotal clinical trial for the Ottava robotic surgical system. If the trial goes...
‘Evo’ AI can design complete genomes
BioWorld Science
The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...
Apollo signs near-$1B deal for Sunshine’s FGF21/GLP-1 injection
BioWorld Asia
Apollo Therapeutics Group Ltd. and Sunshine Lake Pharma Co. Ltd. inked a potential $938 million licensing deal for APL-18881 (HEC-88473), Sunshine’s dual...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.